Analysis Metabolite Name Measured Value Units Cell Type Stimulation
Reversed phase NEGATIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M-H)-13400000Peak areaPAK Untreated
Reversed phase NEGATIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M-H)-14100000Peak areaBS4 TNF-alpha
Reversed phase NEGATIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M-H)-15900000Peak areaPAK IL-17A
Reversed phase NEGATIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M-H)-16400000Peak areaPAK TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M-H)-17200000Peak areaBS4 IL-17A
Reversed phase NEGATIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M-H)-17400000Peak areaPAK TNF-alpha
Reversed phase NEGATIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M-H)-17500000Peak areaBS4 IFN-G
Reversed phase NEGATIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M-H)-18200000Peak areaBS4 Untreated
Reversed phase NEGATIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M-H)-19300000Peak areaBS4 TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M-H)-20100000Peak areaPAK IFN-G
Reversed phase NEGATIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M-H)-21600000Peak areaHAHA TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M-H)-21800000Peak areaHAHA IFN-G
Reversed phase NEGATIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M-H)-23100000Peak areaHAHA IL-17A
Reversed phase NEGATIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M-H)-23300000Peak areaHAHA TNF-alpha
Reversed phase NEGATIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M-H)-28600000Peak areaHAHA Untreated
Reversed phase POSITIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M+H)+3115473Peak areaPAK Untreated
Reversed phase POSITIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M+H)+3383523Peak areaPAK TNF-alpha
Reversed phase POSITIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M+H)+3402563Peak areaPAK IL-17A
Reversed phase POSITIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M+H)+3402904Peak areaBS4 TNF-alpha
Reversed phase POSITIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M+H)+3441154Peak areaHAHA IL-17A
Reversed phase POSITIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M+H)+3540772Peak areaBS4 IL-17A
Reversed phase POSITIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M+H)+3586786Peak areaHAHA Untreated
Reversed phase POSITIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M+H)+3650429Peak areaHAHA TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M+H)+3659285Peak areaHAHA TNF-alpha
Reversed phase POSITIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M+H)+3763277Peak areaPAK TNF-alpha+IL-17A
Reversed phase POSITIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M+H)+3768408Peak areaBS4 IFN-G
Reversed phase POSITIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M+H)+3892448Peak areaHAHA IFN-G
Reversed phase POSITIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M+H)+3942215Peak areaPAK IFN-G
Reversed phase POSITIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M+H)+4032471Peak areaBS4 Untreated
Reversed phase POSITIVE ION MODE5-OXOPROLINE (CAS# 4042-36-8); (M+H)+4310134Peak areaBS4 TNF-alpha+IL-17A

Return to search page
  logo